The Medicines Hiding in Us… Also, Potatoes

TL;DR

Researchers have discovered that RNA methylation can affect the immune system's response to viruses, potentially leading to a broad-spectrum solution for treating various infections. Additionally, a compound called solanimycin, produced by a bacterium found in potatoes, shows promise as an antifungal treatment for both plants and humans.

Transcript

This SciShow News video is supported by Shopify, a commerce platform that helps you start, grow, and manage your business. Head to shopify.com/scishowstarter to learn more and for a 14-day free trial of their new Starter Plan. [♪ INTRO] Our immune system is a pretty amazing adaptation, capable of defending us against all manner of infections. But i... Read More

Key Insights

• ❓ RNA methylation affects the immune system's response to viral infections, and disabling an enzyme used in this process can trigger a heightened immune response.
• 🤙 A compound called solanimycin, produced by a bacterium found in potatoes, has shown antifungal properties that could be utilized for human infections.
• 🎯 Broad-spectrum antiviral drugs that target RNA methylation or utilize compounds like solanimycin could potentially revolutionize disease treatment.
• 🥺 Studying natural sources, such as bacteria and plants, can lead to the discovery of new disease treatments.
• 🤗 The ability to manipulate the immune system's response could open up new avenues for combating various infections.
• ❓ Exploring the interactions between microorganisms may unveil hidden defense mechanisms that can be utilized in drug development.
• 🥺 Identifying and studying compounds produced by bacteria and other organisms can lead to the discovery of potent antimicrobial agents.

Questions & Answers

Q: How does disabling an enzyme used in RNA methylation affect the immune system's response to viral infections?

When the enzyme is disabled, the cells produce more interferons, which interfere with viral infection. This suggests that disabling the enzyme triggers a response in the immune system, making it more alert to potential invasions.

Q: Can the broad-spectrum antiviral drug developed from this research work against all types of infections?

The drug would most likely work against a wide range of viruses since interferon is a general response of the immune system. However, more experiments are needed to determine its effectiveness against different virus strains.

Q: How does solanimycin work against fungi?

The exact mechanism of action is still unclear, but exposure to solanimycin leads to noticeable effects on fungi. The compound seems to be able to disrupt the growth and survival of fungal cells.

Q: Why doesn't the bacterium continually produce solanimycin?

Solanimycin production is considered to be expensive for the bacterium, so it only produces the compound when it is necessary to defend against fungal competitors.

Summary & Key Takeaways

• A study published in PNAS explored how RNA methylation affects the immune system's response to viral infections. Disabling an enzyme used in RNA methylation resulted in increased production of interferons, proteins that interfere with viral infection, potentially leading to the development of a broad-spectrum antiviral drug.

• Researchers studying a bacterium called Dickeya solani discovered that it can produce a compound called solanimycin, which has antifungal properties. Solanimycin has shown efficacy against various fungi, including Candida albicans, a human pathogen, raising the possibility of using it as a treatment for fungal infections in humans.